INTRODUCTION
Human complement component C2 is an HLA class III gene product that is involved in activation of the complement system, the principal effector mechanism of the humoral immune response. C2 shares homology with the classical serine proteinases, but is unusual in having a catalytic chain with a much extended N-terminus (Christie et al., 1980; Reid & Porter, 1981; Gagnon, 1984) . Activation of the complement cascade triggers a number of biological effects that assist the clearance of immune complexes from the blood, including opsonization of particles, release of inflammatory peptides and lysis of cellular antigens (Fothergill & Anderson, 1978; Lachmann, 1979; Reid & Porter, 1981) . In the classical pathway the zymogen form of C2 becomes associated with C4b bound to immune aggregates, is cleaved by CI and forms the C3 convertase. C2 is analogous in structure, function and mechanism of activation to Factor B, which in association with C3b forms the C3 convertase of the alternative pathway. The activities of both C3 convertases are subsequently modified by the binding of additional C3b to become C5 convertases, which initiate activation of the late components C5-C9, leading to lysis ofcellular antigens (Reid & Porter, 1981) .
Structural analysis of C2 has been hampered by the low concentration of the protein in plasma, and by its susceptibility to proteolysis during isolation (Kerr, 1979) , but sufficient amino acid sequence data were obtained (Kerr & Porter, 1978; Parkes et al., 1983; Gagnon, 1984) to permit the use of mixed oligodeoxyribonucleotide probes to identify partial cDNA clones (Bentley & Porter, 1984) . The present paper reports the complete primary structure of the C2 zymogen and putative signal peptide determined by cDNA cloning and nucleotide sequence analysis. C2 is closely related in primary structure to Factor B. The two proteins are related to both the classical serine proteinase family and a novel class of plasma proteins characterized by the occurrence of a common repeat structure of approx. 60 amino acid residues, and which includes the three complement regulatory cofactors C4b-binding protein (C4BP), Factor H and complement receptor type I (CR1), plus the non-complement proteins /J2-glycoprotein I (fl21) and interleukin-2 (IL-2) receptor. Chirgwin et al. (1979) , and fractionated on 15-30% (w/v) sucrose gradients. All material of 18 S and above was collected by ethanol precipitation and further purified by oligo(dT)-cellulose chromatography (Aviv & Leder, 1972) . Double-stranded DNA was synthesized from 40 ,ug of RNA by standard procedures Wickens et al., 1978) , then treated with S1 nuclease, and termini were repaired in a further DNA synthesis reaction in vitro by using the Klenow subfragment of DNA polymerase I. The DNA was fractionated on a 15-40% (w/v) sucrose gradient. All material longer than 1 kb was collected, ligated into CCCACGATzll TI0   80   90-ffCIXaix,TTCC G.UWM---D GAAX;T   10  20  30  40   so   60  70   80   90  100  110  120   10  20  30 40 CTrCAGCCATGOCTGGGCrCCrGGGAGCMICTCACCTACTCCTGCCOCCAGGGCCrGTACCCATSCCAOCATCACGGCTGTGCAAGAGCAGOGCJ   130  140  150  160  170  ISO  190  200  210  220  230  240   50  60  70 80 AAGCTGGLGGACTGGAGAGA CGA TGAGCTAG  1210  1220  1230  1240  1250  1260  1270  1280  1290  1300  1310  1320 410 420 430 440 .TGACAOCACAAC  1450  1460  1470  1480  1490  1500  1510  1520  1530  1540  1550  1560   490   500 510 520 FAAAMTCC   1570  1580  1590  1600  1610  1620  1630  1640  1650  1660  1670  1680 530 540 550 560 AACAGTrCCTATaCAGTGGGACC   1930  1940  1950  1960  1970  1980  1990  2000  2010  2020  2030   2040   650  660  670 680 GT   2050  2060  2070  2080  2090  2100  2110  2120  2130  2140  2150  2160 690 700 710 720 PvuII-cut and phosphatase-treated pAT153/PvuII/8 (Anson et al., 1984) and the products of the reaction were transformed into competent E. coli MC1061 cells (Casadaban & Cohen, 1980) . The library was amplified by growth for 2 h in 2 x TY broth (Maniatis et al., 1982) containing 100 jig of ampicillin/ml and stored in aliquots at -70 'C. The complexity of the library before amplification was more than 1 x 105 transformants, of which about 50%O contained inserts of over 1 kb.
MATERIALS AND METHODS
Screening of cDNA libraries The 18 S + 28 S cDNA library, plus a 28 S library kindly provided by Dr. K. T. Belt (Belt et al., 1984 ) and a 20-22 S library kindly provided by Professor G. G. Brownlee (library II in Anson et al., 1984) , were screened on Whatman 541 filters (Gergen et al., 1979) . Probes were prepared by standard procedures (Maniatis et al., 1982) as follows. The insert of clone pC201 (Bentley & Porter, 1984) was excised with BamHI and HindlIl and purified by elution from a 4% polyacrylamide native thin gel. The 1 kb BglII-BamHI genomic fragment of cos 10 was purified by electro-elution from agarose and subcloned into BamHI-cut and phosphatase-treated pAT. The insert of one resulting subclone pBgB2 was excised with XhoI and HindlIl and purified by elution from polyacrylamide. DNA fragments were nicktranslated to specific radioactivities of over I x 108 c.p.m./,tg (Rigby et al., 1977) . Nucleotide sequence analysis Inserts of cDNA clones were either randomly fragmented by sonication or treated with restriction enzymes. Overhanging 5'-termini were repaired by use of the Klenow fragment of DNA polymerase I in a fill-in reaction and subcloned into MI 3mp 8 or M13mp 9 (Messing & Vieira, 1982) by using E. coli TG1. Dideoxy sequence analysis followed the method of Sanger et al. (1977) , and the products of the sequence reactions were resolved on buffer-gradient gels (Biggin et al., 1983) . Sequence data were processed by using the programs of Staden (1982) . The sequence was determined at least once and maximally three times on both strands of the DNA.
RESULTS AND DISCUSSION
Structure and organization of C2 mRNA C2 cDNA clones were isolated from an 18 S+ 28 S human liver library (see the Materials and methods section), a 28 S library (Belt et al., 1984 ) and a 20-22 S library (Anson et al., 1984) , with as probes either the fragment C2 cDNA clone pC201 (Bentley & Porter, 1984) or a 1 kb BamHI-BglII restriction fragment encoding the 5'-end of the C2 gene . Analysis of five clones resulted in determination of 2619 nucleotide residues of sequence from the 5'-terminal non-coding region of the C2 mRNA to the polyadenylation site (see Fig. 1 ). The sequence presented here agrees with both the nucleotide sequence of the 5'-end of the C2 gene and the results of amino acid sequence analysis except at amino acid residues 10 and 14 (Kerr, 1979; Kerr & Gagnon, 1982; Parkes et al., 1983; Gagnon, 1984) . The sequence also agrees with the data of Woods et al. (1984) except at nucleotide residues 752, 758, 759 and 813. The sequence of nucleotides 752-765 in Fig. 1 is 5'-AAAGCCTGGGCCGT-3' (14 in total) and was determined from two cDNA clones. The sequence of Woods et al. (1984) is 5'-CAAGCCAGGCCGT-3' (13 in total) in the equivalent region. Nucleotide 813 in Woods et al. (1984) is an A residue in contrast with a G in Fig. 1 .
The size of the polyadenylated C2 mRNA is 2.9 kb from Northern-blot analysis (Bentley & Porter, 1984 (Bause, 1983) ], whereas there are only two in C2b (shown boxed in Fig. 1 ). The organization of C2 mRNA and protein closely resembles that of Factor B (see Fig. 2 ). The catalytic chain of C2a
The N-terminal halves of the catalytic chains C2a (residues 224 445) and Bb (residues 235-456) show no homology to the classical serine proteinases or any other protein sequences determined to date. The C-terminal half of C2a (residues 446-732) is homologous to other serine proteinases, as shown in the alignment with human Factor B and bovine trypsin (Fig. 3) . The homology between C2 and Factor B extends over the entire length of the two proteins and is 390% (identities), or 5000 including conservative amino acid replacements. The homology of C2 to trypsin is 17% (27% including conservative changes). The majority of half-cystine residues are conserved among all three sequences in this region, as are the residues around the active-site aspartic acid (Asp-541), histidine (His-487) and serine residues, and also those in the region of the secondary substrate binding site (Ser-Trp-Gly 678-680 in C2). There is no direct correspondent to the Asp-189 of trypsin, which lies at the bottom of the substrate-binding pocket and interacts with positively charged arginine and lysine side chains. The nearest aspartic acid residue conserved in C2 and Factor B is at position 651 (C2 numbering) and corresponds to position 187 in trypsin.
The alignment shows five regions in the catalytic domain of C2 that have no counterparts in trypsin. They are residues 532-540, 568-574, 588-596, 621-633 and 698-712 (see Fig. 3 homology (see Fig. 4a ). The triple repeat was previously observed in Ba, and it was postulated that the structure arose by repeated duplication of a single primordial segment (Morley & Campbell, 1984 --G5QKNYPGVYTKV-------CCNYVWIASN Fig. 3 . Alignment of amino acid sequence of human C2 and Factor B (FB) with the catalytic chain of bovine trypsin (TP) Data for Factor B is taken from , ), Campbell & Porter (1983 and Morley & Campbell (1984) . The bovine trypsin sequence and alignment are taken from Young et al. (1978) and Gagnon (1984) . Numbering refers to the C2 protein sequence of Fig. 1 . Identical amino acids in two or more sequences are 'boxed'.
was exactly encoded by a separate exon in the Factor B gene (Morley, 1984; Campbell et al., 1984) , which defined the evolutionary unit at the level of the DNA.
The 60-amino-acid-residue repeat structure has also been observed in the complement regulatory proteins C4BP and Factor H (Kristensen et al., 1985; Sim et al., 1986) and CR1 (Klickstein et al., 1985) and also in the non-complement serum protein Al21 (Lozier et al., 1984) and IL-2 receptor (Leonard et al., 1984; Nikaido et al., 1984; Cosman et al., 1984) (Morley, 1984) . receptor contains two repeats that conform to the consensus pattern established for the complement proteins plus A321. Although the IL-2 receptor repeats are non-contiguous (residues 1-60 and 102-164; see Fig. 4c ), the published exon structure of the human IL-2 receptor gene showed that amino acid residues 1-64 and 102-174 are each encoded in a discrete exon (Ishida et al., 1985; Leonard et al., 1985) . (Morley & Campbell, 1984) , C4BP , human Factor H (H) (partial sequence data; Sim et al., 1986 ) and fl21 (Lozier et al., 1984) . The alignment of the five repeats of/21 was modified as described in the text before evaluation of the f821 consensus. In each consensus, large letters denote amino acid residues conserved in every repeat of the protein; small letters denote amino acid residues conserved in over 60% of the repeats of the protein. The numbering is a close approximation to a consensus and is subject to some variation in individual repeats. (c) The two repeats of human IL-2 receptor and proposed consensus. Data and amino acid numbering are from Leonard et al. (1984 ), Nikaido et al. (1984 and Cosman et al. (1984) . 1 indicates the first amino acid residue of the mature polypeptide chain.
encoded by a separate exon, which may have arisen for example by mutation of intron sequences to generate a novel exon, or by an exon-shuffling process as described by Gilbert (1978) . C2b is believed to be involved in the initial Mg2+-dependent interaction between C2 and C4b during the formation of the classical-pathway C3 convertase (Nagasawa & Stroud, 1977; Kerr, 1980) . C4BP also binds to C4b during subsequent inactivation of the convertase (Gigli et al., 1979) . The C4b-binding domain of C4BP has been localized to an N-terminal 48 kDa fragment obtained by chymotrypsin digestion of the intact molecule (Fujita et al., 1985; .
The tandem repeat structure common to the N-terminal region of C2b and C4BP may therefore constitute a C4b-binding domain in both molecules. In the formation and subsequent inactivation of the alternative-pathway C3 convertase, Ba and Factor H have analogous roles to C2b and C4BP respectively (Gotze & Miiller-Eberhard, 1971; Hunsicker et al., 1973; Gigli et al., 1979) . The C3b-binding domain of Factor H has been localized to a 35 kDa N-terminal fragment generated by trypsin digestion (Alsenz et al., 1984) . The homologous tandem repeats in N-terminal parts of Ba and Factor H therefore reflect their common role in C3b binding. The complement receptor protein CR1 is another member of the functionally related group of regulatory components comprising Factor H and C4BP (Holers et al., 1985) . Like Factor H and C4BP, CR1 contains a C3b-binding domain (Sim, 1985) ; part of the structure of CR1 is also composed of tandem repeat units of approx. 60 amino acid residues with a consensus similar to those of Fig. 4(b) (Klickstein et al., 1985) . The location of the C3b-binding domain in CR1 relative to the repeats has not been established. C2 and Factor B constitute a unique class of serine proteinases that possess catalytic chains with much extended N-termini. They are also unusual in that they share a homologous relationship with a second and novel class of proteins typified by the presence of a 60-amino-acid-residue repeat structure. The majority of members of this family found to date are regulatory proteins of the complement system, but the discovery that the non-complement proteins fl21 and IL-2 receptor have the same structural features suggests that the 60-amino-acid-residue repeat, and therefore this novel protein family, may turn out to be widespread.
